IQVIA_Rules_Based_Medicine_Logo - rgb

(+01) 512 835 8026

Email us

Type your search term and press "enter."

Matrix Metalloproteinase-3

Matrix Metalloproteinase-3

Matrix Metalloproteinase-3 (MMP-3), also termed Stromelysin-1, can degrade numerous extracellular matrix (ECM) substrates such as fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. MMP-3 activates procollagenase and MMP-9. It can also release cell surface molecules such as heparin-binding EGF-like growth factor and TNF-alpha and inactivate several serine proteinase inhibitors.

Swiss-Prot Accession Number: P08254


Bibliography

Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer (2016) Saif MW, Knost JA, Chiorean EG, Kambhampati SR, Yu D, Pytowski B, Qin A, Kauh JS, ONeil BH Cancer Chemother Pharmacol

medical_services Therapy Indications

Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity (2012) Schuurhof A, Bont L, Hodemaekers HM, de Klerk A, de Groot H, Hofland RW, van de Pol AC, Kimpen JL, Janssen R Eur Respir J. 2012 Jun;39(6):1475-81

medical_services Therapy Indications

2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting (2011) Bouwman FG, de Roos B, Rubio-Aliaga I, Crosley LK, Duthie SJ, Mayer C, Horgan G, Polley AC, Heim C, Coort SL, Evelo CT, Mulholland F, Johnson IT, Elliott RM, Daniel H, Mariman EC BMC Med Genomics. Mar 25;4(1):24. [Epub ahead of print]

medical_services Therapy Indications

Matrix metalloproteinases during and outside of migraine attacks without aura. (2009) Ashina M, Tvedskov JF, Lipka K, Bilello J, Penkowa M, Olesen J Cephalalgia 30: 303-310.

medical_services Therapy Indications